Stay ahead of the competition with Standout.work - your AI-powered talent-to-startup matching platform.
| Date | Price Target | Rating | Analyst |
|---|---|---|---|
| 5/27/2026 | Buy → Neutral | Seaport Research Partners | |
| 8/26/2025 | $38.00 | Neutral → Buy | Seaport Research Partners |
| 5/28/2025 | $23.00 | Hold | Truist |
| 3/5/2024 | $43.00 → $31.00 | Buy → Neutral | B. Riley Securities |
| 12/15/2023 | $43.00 | Buy | B. Riley Securities |
| 12/4/2023 | Buy → Neutral | Seaport Research Partners | |
| 3/28/2023 | $50.00 | Neutral → Buy | Seaport Research Partners |
| 8/30/2022 | Buy → Neutral | Seaport Research Partners |
--Sales and Bottom Line Improvement Exceed Expectations-- -- Journeys Comparable Sales +5%, Johnston & Murphy Comparable Sales +7%-- --Seventh Consecutive Quarter of Positive Total Comparable Sales Growth-- --Announces New $40 to $50 million Cost Savings Program-- --Raises Full Year EPS Outlook Range to $2.00 to $2.40-- Genesco Inc. (NYSE:GCO) today reported first quarter results for the three months ended May 2, 2026. First Quarter Fiscal 2027 Financial Summary Net sales of $487 million increased 3% compared to Q1FY26 Comparable sales increased 2%, with stores up 3% while e-commerce was flat Gross margin improved 30 basis points compared to last year Selling and administrat
Genesco Inc. (NYSE:GCO) today announced that the Company will report financial results for the first quarter fiscal 2027 on May 29, 2026, before the market opens, and hold its quarterly earnings conference call at 7:30 a.m. (Central time) the same day. A live audio webcast of the conference call will be available at https://www.genesco.com/investor-relations/investor-overview An audio archive of the call will be available for up to one year at https://www.genesco.com/investor-relations/investor-overview In addition, a summary of the first quarter fiscal 2027 results will be available on the Genesco website on May 29, 2026 at https://www.genesco.com/investor-relations/investor-overv
Genesco Inc. (NYSE:GCO) today announced the appointment of Ashley Randolph as Vice President and Chief Accounting Officer, effective May 5, 2026. A 20-year veteran of Genesco, Randolph most recently served as Vice President and Corporate Controller, a role she has held since 2024. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20260505092710/en/Ashley Randolph - Genesco In her new role, Randolph will oversee the Company's accounting operations, financial controls and compliance, including financial statements, accounting policy, and SEC reporting, while driving continued efficiencies across the function. "Ashley is a greatly res
3 - GENESCO INC (0000018498) (Issuer)
4 - GENESCO INC (0000018498) (Issuer)
4 - GENESCO INC (0000018498) (Issuer)
4 - GENESCO INC (0000018498) (Issuer)
PREC14A - GENESCO INC (0000018498) (Subject)
10-K/A - GENESCO INC (0000018498) (Filer)
8-K - GENESCO INC (0000018498) (Filer)
Seaport Research Partners downgraded Genesco from Buy to Neutral
Seaport Research Partners upgraded Genesco from Neutral to Buy and set a new price target of $38.00
Truist initiated coverage of Genesco with a rating of Hold and set a new price target of $23.00
Genesco Inc. (NYSE:GCO) today announced the appointment of Ashley Randolph as Vice President and Chief Accounting Officer, effective May 5, 2026. A 20-year veteran of Genesco, Randolph most recently served as Vice President and Corporate Controller, a role she has held since 2024. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20260505092710/en/Ashley Randolph - Genesco In her new role, Randolph will oversee the Company's accounting operations, financial controls and compliance, including financial statements, accounting policy, and SEC reporting, while driving continued efficiencies across the function. "Ashley is a greatly res
Establishment Labs Holdings Inc. (NASDAQ:ESTA), a global medical technology company dedicated to improving women's health and wellness, principally in breast aesthetics and reconstruction, today announced a strategic leadership transition of Raj Denhoy, current Chief Financial Officer to Senior Vice President, Global Strategy, and the appointment of Cassandra "Sandra" Harris to Senior Vice President and Chief Financial Officer, effective March 9, 2026. "Over the past few years, we have been focused on driving efficient execution and scalability. With the company well positioned for its next chapter of growth, we are creating additional leadership capacity to maintain operational momentum
--A Proven Executive with Deep Retail Expertise and Experience Implementing Human Resources Transformation-- Genesco Inc. (NYSE:GCO) today announced that Kyle Polischuk has been named Chief Human Resources Officer, leading the enterprise wide human resources function for the footwear focused lifestyle retailer and branded company. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20250107024161/en/Kyle Polischuk , Genesco Chief Human Resources Officer (Photo: Business Wire) "Kyle's strategic leadership and exceptional track record building dynamic organizations, developing talent, and promoting strong cultures will make a tremendou
SC 13G - GENESCO INC (0000018498) (Subject)
SC 13G/A - GENESCO INC (0000018498) (Subject)
SC 13G/A - GENESCO INC (0000018498) (Subject)
--Sales and Bottom Line Improvement Exceed Expectations-- -- Journeys Comparable Sales +5%, Johnston & Murphy Comparable Sales +7%-- --Seventh Consecutive Quarter of Positive Total Comparable Sales Growth-- --Announces New $40 to $50 million Cost Savings Program-- --Raises Full Year EPS Outlook Range to $2.00 to $2.40-- Genesco Inc. (NYSE:GCO) today reported first quarter results for the three months ended May 2, 2026. First Quarter Fiscal 2027 Financial Summary Net sales of $487 million increased 3% compared to Q1FY26 Comparable sales increased 2%, with stores up 3% while e-commerce was flat Gross margin improved 30 basis points compared to last year Selling and administrat
Genesco Inc. (NYSE:GCO) today announced that the Company will report financial results for the first quarter fiscal 2027 on May 29, 2026, before the market opens, and hold its quarterly earnings conference call at 7:30 a.m. (Central time) the same day. A live audio webcast of the conference call will be available at https://www.genesco.com/investor-relations/investor-overview An audio archive of the call will be available for up to one year at https://www.genesco.com/investor-relations/investor-overview In addition, a summary of the first quarter fiscal 2027 results will be available on the Genesco website on May 29, 2026 at https://www.genesco.com/investor-relations/investor-overv
--Journeys Q4 Comparable Sales +12%, Overall Comparable Sales +9%-- --Sixth Consecutive Quarter of Positive Comparable Sales Growth-- --Operating Income Increased 11% for Q4 and Increased 24% for Fiscal 2026-- Genesco Inc. (NYSE:GCO) today reported fourth quarter and full fiscal year results for the three and twelve months ended January 31, 2026. Fourth Quarter Fiscal 2026 Financial Summary Net sales of $800 million increased 7% compared to Q4FY25 Comparable sales increased 9%, with stores up 9% and e-commerce up 8% E-commerce sales represented 31% of retail sales compared to 30% last year Selling and administrative expenses leveraged 140 basis points compared to last year